Author Topic: Dorgan Drug Importation Amendment Infringes On Intellectual Property  (Read 1418 times)

0 Members and 1 Guest are viewing this topic.

Offline NateRiver

  • Probationary (Probie)
  • Posts: 89
  • Reputation: +14/-5
Quote
"Without any assurance that intellectual property will be respected and protected, not only drug makers, but other companies as well, will avoid investing in developing new products since they risk having their investments effectively expropriated by the government”
Intellectual Property

Offline thundley4

  • Hero Member
  • *****
  • Posts: 40571
  • Reputation: +2224/-127
Screw the intellectual property rights part of this. It would allow drugs to be imported with FDA testing or approval. WTF?  Granted, I think at times the FDA takes too long to approve drugs, but on the other hand they often approve drugs with side effects that are worse than what is being treated.

That being said, maybe this amendment is a poison pill to kill the main bill that it is attached to:

H.R.1256

To protect the public health by providing the Food and Drug Administration with certain authority to regulate tobacco products, to amend title 5, United States Code, to make certain... (Placed on Calendar in Senate) http://thomas.loc.gov/cgi-bin/query/D?c111:4:./temp/~c111zfQQUu::
Quote
SEC. 919. USER FEES.

`(a) Establishment of Quarterly Fee- Beginning on the date of enactment of the Family Smoking Prevention and Tobacco Control Act, the Secretary shall in accordance with this section assess user fees on, and collect such fees from, each manufacturer and importer of tobacco products subject to this chapter. The fees shall be assessed and collected with respect to each quarter of each fiscal year, and the total amount assessed and collected for a fiscal year shall be the amount specified in subsection (b)(1) for such year, subject to subsection (c).
`(b) Assessment of User Fee-
`(1) AMOUNT OF ASSESSMENT- The total amount of user fees authorized to be assessed and collected under subsection (a) for a fiscal year is the following, as applicable to the fiscal year involved:
`(A) For fiscal year 2009, $85,000,000 (subject to subsection (e)).
`(B) For fiscal year 2010, $235,000,000.
`(C) For fiscal year 2011, $450,000,000.
`(D) For fiscal year 2012, $477,000,000.
`(E) For fiscal year 2013, $505,000,000.
`(F) For fiscal year 2014, $534,000,000.
`(G) For fiscal year 2015, $566,000,000.
`(H) For fiscal year 2016, $599,000,000.
`(I) For fiscal year 2017, $635,000,000.
`(J) For fiscal year 2018, $672,000,000.
`(K) For fiscal year 2019 and each subsequent fiscal year, $712,000,000.

Offline NateRiver

  • Probationary (Probie)
  • Posts: 89
  • Reputation: +14/-5
Thanks for the link and input thundley4. I agree in the long run the FDA is doing a good job protecting us even if we think they are slow.